Wild and Gong [118] highlighted several biomarkers used to monitor AF exposure, including urinary metabolites such as AFM1, AFB1-N7-Gua, AFP1, AFQ1, and AFB1-mercapturic acid, as well as AF-albumin adducts [119]. This evidence concerns the gene ALB and atrial fibrillation.